Provided by Tiger Trade Technology Pte. Ltd.

Corbus Pharmaceuticals

8.24
-0.6200-7.00%
Post-market: 8.360.1200+1.46%17:07 EDT
Volume:646.69K
Turnover:5.44M
Market Cap:159.37M
PE:-1.35
High:8.79
Open:8.75
Low:8.21
Close:8.86
52wk High:20.56
52wk Low:7.12
Shares:19.34M
Float Shares:17.42M
Volume Ratio:0.99
T/O Rate:3.71%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.0889
EPS(LYR):-5.9000
ROE:-95.58%
ROA:-53.00%
PB:1.56
PE(LYR):-1.40

Loading ...

Corbus Q1 FY26 net loss widens to $23 million; operating expenses rise to $24.3 million

Reuters
·
May 12

Corbus Pharmaceuticals Reports Q1 2026 Financial Results and Provides a Corporate Update

THOMSON REUTERS
·
May 12

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 06

Corbus hosts ASCO KOL event on updated CRB-701 HNSCC Phase 1/2 data

Reuters
·
May 05

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains

Dow Jones
·
May 05

MercadoLibre, T-Mobile, Corbus, Celestica, Elevance Trending With Analysts

TIPRANKS
·
May 02

Corbus Pharmaceuticals Holdings Inc. Stock Rallies 4.3%, Outperforms Peers

Dow Jones
·
May 02

Corbus Pharmaceuticals Holdings Inc expected to post a loss of $1.22 a share - Earnings Preview

Reuters
·
May 01

Corbus Pharmaceuticals Initiated at Buy by Guggenheim

Dow Jones
·
Apr 30

U.S. RESEARCH ROUNDUP-Coca-Cola Co, Mondelez, Zeta Global Holdings

Reuters
·
Apr 29

Corbus Pharmaceuticals Holdings Inc : Guggenheim Initiates Coverage With Buy Rating; Target Price $45

THOMSON REUTERS
·
Apr 29

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Apr 29

Corbus Pharmaceuticals initiated with a Buy at Guggenheim

TIPRANKS
·
Apr 29

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
Apr 25

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Apr 23

Corbus Pharmaceuticals Announces Abstracts Accepted for Presentation at ASCO 2026 Featuring Updated Clinical Data for CRB-701

GlobeNewswire
·
Apr 22

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Apr 22

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Apr 17

Corbus Pharmaceuticals Updates Executive Employment Agreements and Protections

TIPRANKS
·
Apr 17

Corbus CEO Cohen base salary rises to $673,625 under amended employment agreement

Reuters
·
Apr 17